Tim Freeborn

Tim Freeborn

Analyst-Equity at Slater Investments Ltd.

Finance
Commercial Services
Consumer Services

Profile

Mr. Timothy C.
Freeborn is an Analyst at Slater Investments Ltd.
He joined the firm in February 2017 and serves on the Investment Committee.
Since qualifying as a Chartered Accountant, Mr. Freeborn has had a varied career.
For many years he was a City writer at The Daily Mail, he has also edited an investment newsletter and contributed to Shares Magazine.
This was followed by several years as a Stockbroking Analyst at Evolution Securities and Xcap Securities covering growth companies.
Before joining Slater Investments, he spent four years as the Chief Financial Officer of Silence Therapeutics, an Aim listed biotech company and latterly ran its laboratories in Berlin.
He received his undergraduate degree from the University College London.

Tim Freeborn active positions

CompaniesPositionStart
Analyst-Equity 2017-01-31
All active positions of Tim Freeborn

Former positions of Tim Freeborn

CompaniesPositionEnd
SILENCE THERAPEUTICS PLC Director of Finance/CFO 2016-07-17
Hume Capital Securities Plc (Broker) Director of Research - Equity 2012-09-30
Evolution Securities Ltd. Analyst-Equity 2009-07-09
HUME CAPITAL SECURITIES PLC Corporate Officer/Principal -
See the detail of Tim Freeborn's experience

Training of Tim Freeborn

University College London Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tim Freeborn's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
SILENCE THERAPEUTICS PLC

Commercial Services

Private companies4
Evolution Securities Ltd.

Finance

Hume Capital Securities Plc (Broker)

Finance

Finance

Finance

See company connections